Employee-related Liabilities, Current of NEUROCRINE BIOSCIENCES INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
NEUROCRINE BIOSCIENCES INC quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Employee-related Liabilities, Current for the quarter ending 31 Dec 2025 was $128,800,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $128,800,000 +$21,300,000 +20% 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q3 2025 $105,100,000 +$28,000,000 +36% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $84,600,000 +$24,800,000 +41% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $57,500,000 +$14,900,000 +35% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $107,500,000 +$21,300,000 +25% 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q3 2024 $77,100,000 +$8,500,000 +12% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $59,800,000 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $42,600,000 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $86,200,000 +$13,400,000 +18% 31 Dec 2023 10-K 10 Feb 2025 2024 FY
Q3 2023 $68,600,000 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q4 2022 $72,800,000 +$22,200,000 +44% 31 Dec 2022 10-K 09 Feb 2024 2023 FY
Q4 2021 $50,600,000 +$12,400,000 +32% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q4 2020 $38,200,000 -$700,000 -1.8% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q4 2019 $38,900,000 +$11,559,000 +42% 31 Dec 2019 10-K 05 Feb 2021 2020 FY
Q4 2018 $27,341,000 +$2,440,000 +9.8% 31 Dec 2018 10-K 07 Feb 2020 2019 FY
Q4 2017 $24,901,000 +$15,342,000 +160% 31 Dec 2017 10-K 08 Feb 2019 2018 FY
Q4 2016 $9,559,000 +$2,201,000 +30% 31 Dec 2016 10-K 13 Feb 2018 2017 FY
Q4 2015 $7,358,000 +$838,000 +13% 31 Dec 2015 10-K 14 Feb 2017 2016 FY
Q4 2014 $6,520,000 +$3,117,000 +92% 31 Dec 2014 10-K 11 Feb 2016 2015 FY
Q4 2013 $3,403,000 -$408,000 -11% 31 Dec 2013 10-K 09 Feb 2015 2014 FY
Q4 2012 $3,811,000 -$31,000 -0.81% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 $3,842,000 31 Dec 2011 10-K 08 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.